Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioPortfolio's Approved Drugs Database

Fabrazyme

Agalsidase Beta

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Press Releases About Fabrazyme:

 BioPortfolio Logo
Genzyme Reports Strong Second-Quarter Growth 23rd July, 2008 Genzyme Corporation
CAMBRIDGE, Mass., July 23 /PRNewswire-FirstCall/ -- Genzyme Corporation (Nasdaq: GENZ) today reported strong sales and profit growth in the second quarter, along with significant progress in its
Fabrazyme Approved 1st January, 2001 Biotracker
  Biotech Tracker News - Fabrazyme Approved 
Wong’s BioTech Stock Report - focus on the pipeline Fabrazyme, Replagal 1st January, 1970 Biotechsage
  Wong’s BioTech Stock Report - focus on the pipeline Fabrazyme, Replagal &
Biotech Tracker News - Replagal Data Do Not Address Regulatory 1st January, 1970 Biotracker
  Biotech Tracker News - Replagal Data Do Not Address Regulatory Shortcomings  
Biotech Tracker News - Another Replagal Setback 1st January, 1970 Biotracker
  Biotech Tracker News - Another Replagal Setback  November 27,

This page has been viewed 18 times Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Fabrazyme across BioPortfolio, or for Fabrazyme Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.